Sun Jong Kim | In Vitro Diagnostics | Science and Technology Pioneer Award

Dr. Sun Jong Kim | In Vitro Diagnostics | Science and Technology Pioneer Award 

Researcher at BioFront | South Korea

Dr. Sun Jong Kim is a highly accomplished biotechnology and life sciences professional whose career reflects sustained contributions to in vitro diagnostics, stem cell science, biomolecular research, and translational biomedical innovation. Equipped with a strong academic foundation including bachelor’s, master’s, and doctoral studies in life sciences, Dr. Sun Jong Kim has developed deep expertise in cellular biology, developmental biology, and molecular mechanisms of pluripotency. His professional journey includes senior research and leadership roles across multiple biomedical organizations, where he has guided R&D programs involving the establishment and maintenance of pluripotent stem cell lines, large-scale microalgae production systems, medical device development, and regulatory preparation for diagnostic technologies. He has contributed to the development of human embryonic stem cell resources, in vitro differentiation platforms, and advanced diagnostic systems applied to areas such as oncology, COVID-19 rapid testing, and point-of-care technologies. His industrial leadership also includes oversight of product development pipelines, quality assurance systems, and multidisciplinary research operations, demonstrating an ability to translate scientific results into usable biomedical solutions that directly support clinical and research infrastructures. His research outputs include numerous scientific publications, national and international presentations, and patents in areas such as stem cell culturing techniques, photobioreactors, and biomaterial-based innovations. The measurable impact of his scholarly contribution is represented by 24 citations by 24 documents, 2 indexed documents, and an h-index of 2, reflecting ongoing engagement and recognition within the scientific community. Dr. Sun Jong Kim’s research interests encompass stem cell biology, human cell culture systems, the regulation of self-renewal and differentiation pathways, bioprocess design, clinical diagnostics, and biotechnology commercialization. His work has been supported by significant research grants and has contributed to advancements in both academic discovery and applied biomedical engineering. In addition to laboratory research, he has played a crucial role in the development, certification, and evaluation of diagnostic medical devices aligned with international regulatory standards and real-world clinical needs. Through his ongoing work at Biofront and other institutions, Dr. Sun Jong Kim continues to drive innovation in science and technology, contributing to advancements that support more accurate diagnostics, greater understanding of biological systems, and the modernization of biomedical tools used in healthcare and life science research.

Profile: Scopus

Featured Publications:

Kim, S. J.,(1999). Isolation of developmentally regulated novel genes based on sequence identity and gene expression patterns. Molecules and Cells, 9, 207–218.

Kim, S. J.,(2001). Ovarian expression of melatonin Mel(1) receptor mRNA during mouse development. Molecular Reproduction and Development, 59, 126–132.

Kim, S. J.,(2003). Isolation and culture of human embryonic stem-like cells from abnormal blastocysts. Korean Journal of Fertility and Sterility, 30, 293–301.

Kim, S. J.,(2003). Establishment and maintenance of human embryonic stem cells on STO, a permanently growing cell line. Biology of Reproduction, 69, 2007–2014.

Kim, S. J.,(2004). Establishment of embryonic germ cells from cultured human primordial germ cells and their differentiation into neuronal cells. Molecules and Cells, 17, 309–315.

Kim, S. J.,(2004). Recent advances in human embryonic stem cell research. Journal of the Korean Medical Association, 918–925.

Kim, S. J.,(2004). Effects of type IV collagen and laminin on the cryopreservation of human embryonic stem cells. Stem Cells, 22, 950–961.

Kim, S. J.,(2004). Available human feeder cells for the maintenance of human embryonic stem cells. Reproduction, 128, 727–735.

Lwin Saing | Plants Taxonomy | Best Researcher Award

Prof. Lwin Saing | Plants Taxonomy | Best Researcher Award

Professor at  Ministry of Higher Education,Myanmar | Myanmar

Prof. Lwin Saing is a highly accomplished botanist and academic leader serving at the Ministry of Higher Education, Myanmar, and the Department of Botany, Mohnyin University. She holds a Ph.D. in Botany with a specialization in Plant Taxonomy and Evolution from the University of Yangon, where her doctoral research focused on the taxonomy and systematics of wild cereal species in Myanmar’s Tanintharyi coastal region. With over two decades of teaching and research experience, she has contributed significantly to advancing the understanding of Myanmar’s diverse flora through her expertise in taxonomy, systematics, and environmental conservation. Her extensive research encompasses wild plants taxonomy, evolutionary studies of grasses and cereals, and the conservation of endangered species. Prof. Lwin Saing has led and collaborated on numerous research projects under the Ministry of Higher Education, focusing on biodiversity conservation, endangered species classification, and ecological sustainability. She has published widely in national and international journals, including MDPI’s Plants, and has received several prestigious awards recognizing her scientific excellence, such as multiple Best Research Awards from the Ministry of Higher Education and distinguished recognitions from major universities in Myanmar. She has also supervised a large number of postgraduate theses, contributing to the development of future researchers in taxonomy and environmental science. In addition to her research, she actively participates in regional academic initiatives, including the South and Southeast Asian University Network, and represents Myanmar in international biodiversity programs. Her involvement in SEAMEO and UNESCO workshops reflects her commitment to advancing sustainable education and promoting ecological awareness. Prof. Lwin Saing’s work bridges taxonomy, ecology, and conservation, playing a vital role in preserving Myanmar’s botanical heritage while contributing to global plant science. Through her research, mentorship, and leadership, she continues to inspire a new generation of botanists, positioning herself as a key figure in Southeast Asia’s efforts toward sustainable biodiversity management and scientific innovation in plant taxonomy.

Featured Publication:

Saing, L. M. (2025). Evolutionary trends of some wild cereal from In-Daw-Gyi Lake, Mohnyin Township, Kachin State. Myanmar Academy of Arts and Science Journal, 24(1).

Saing, L. M. (2024). The differences in morphological characters between some wild species of genus Mussaenda Burm. ex L. Universities Research Journal, 14(5).

Saing, L. M. (2023). Significant differences in morphological characters of Poaceae and Cyperaceae families. Myanmar Academy of Arts and Science Journal, 22(1).

Saing, L. M. (2023). Studying the characters of taxonomy and evolution in giant grass and some crops derived from grass. Mohnyin University Research Journal, 3(2).

Saing, L. M. (2022). Distinct spot characters of some variegated foliage leaves species in Mohnyin University campus. Mohnyin University Research Journal, 2(2).

Kristian Galanti | Genetics and Molecular Biology | Best Researcher Award

Dr. Kristian Galanti | Genetics and Molecular Biology | Best Researcher Award

Medico Specializzando at Università degli Studi G. D’Annunzio di Chieti-Pescara | Italy

Dr. Kristian Galanti is a dedicated Resident Doctor in Cardiovascular Diseases and a PhD candidate in Medical Biotechnologies at the University G. D’Annunzio of Chieti-Pescara. He currently serves as a Research Fellow at the Center for Inherited Cardiovascular Disease, WellSpan Health, USA. His clinical interests include heart failure, cardiomyopathies, and cardiovascular imaging. Dr. Galanti demonstrates exceptional commitment to evidence-based care, contributing to both patient management and research. Known for his strong collaborative ethos, he has been actively involved in multidisciplinary case presentations, cardiovascular imaging, and the development of aetiology-oriented diagnostics in cardiology.

Profile:

 Orcid

Education

Dr. Kristian Galanti’s academic journey began with a Master’s Degree in Medicine and Surgery from the Catholic University of the Sacred Heart, Rome, graduating with professional qualification. He undertook further specialization in Cardiovascular Diseases at the University G. D’Annunzio of Chieti-Pescara and is currently pursuing a PhD in Medical Biotechnologies with a focus on technological innovation in cardiovascular sciences. His education is enriched with certifications in cardiac magnetic resonance, echocardiography, and cardiogenetic imaging from leading Italian and European cardiology societies, highlighting his pursuit of continuous learning and academic excellence in clinical and translational cardiology.

Experience:

Dr. Kristian Galanti has significant clinical and research experience. As a resident physician, he managed cardiology cases, conducted ECGs, and performed advanced imaging techniques including echocardiograms and cardiac MRIs. He also participated in interventional procedures, such as angioplasties and device implantations. At WellSpan Health, he contributes to inherited cardiovascular disease research, integrating imaging and genetics to understand arrhythmogenic mitral valve prolapse. He actively engages in writing scientific articles, producing scientific illustrations, and collaborating in multinational studies, making his dual expertise in clinical and research environments a rare and impactful combination.

Research Interest:

Dr. Kristian Galanti’s research centers on cardiovascular imaging, heart failure, and genetic cardiomyopathies. He is particularly focused on multimodality cardiovascular imaging (CMR, echo) and its correlation with genetic markers in diseases like dilated cardiomyopathy and mitral valve prolapse. His current projects involve imaging-genetics integration for arrhythmic risk stratification. Dr. Galanti is also engaged in drug interaction studies related to novel heart failure therapies. Through systematic reviews and original investigations, his work aims to bridge diagnostic precision with therapeutic personalization, making significant contributions to cardiogenetics and translational cardiovascular science.

Awards and Honors:

Dr. Kristian Galanti has earned several accolades for his academic and research contributions. He received the Italian Society of Cardiology Research Grant for excellence in cardiovascular science. Additionally, he was honored with the “Aldo Prosperini” Award for his original research on ejection fraction evaluation. he won the Best Poster Award at the ANMCO MUMA Congress for his clinical case on Cori-Forbes disease. Previous honors include the Clinical Case Award and Best Abstract Award from the Italian Society of Cardiology, along with the prestigious “Iginio Betti” Foundation Scholarship.

Publications:

Title: Diagnosis and management of dilated cardiomyopathy: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases

Citation: 20

year of Publications: 2024

Title: Arrhythmogenic Cardiomyopathy: Diagnosis and Management

Citation: 18

year of Publications: 2025

Title: Managing drug–drug interactions with mavacamten: a practical guide for clinicians

Citation: 15

year of Publications: 2024

Title: Arrhythmogenic mitral valve prolapse: from clinical features to imaging and genetics

Citation: 10

year of Publications: 2024

Title: Left ventricular non-compaction cardiomyopathy and related phenotypes: diagnosis, prognosis and treatment

Citation: 9

year of Publications: 2025

Title: Current antithrombotic treatments in heart failure: a review

Citation: 7

year of Publications: 2024

Title: Dilated cardiomyopathy evaluation with Imagenomics: combining multimodal cardiovascular imaging and genetics

Citation: 1

year of Publications: 2024

Conclusion:

Dr. Kristian Galanti exemplifies the ideal nominee for a Best Researcher Award. With a solid foundation in clinical cardiology and a progressive academic track in cardiovascular biotechnologies, he combines precision medicine, imaging innovation, and genetic insights in his work. His publication record, international research fellowships, and prestigious recognitions reflect his role as a rising leader in cardiovascular research. Dr. Galanti’s commitment to collaborative science, continual learning, and impactful patient care affirms his readiness to shape the future of cardiovascular medicine with compassion, innovation, and academic rigor.